Literature DB >> 3063498

Use of calciferol and its metabolites and analogues in osteoporosis. Current status.

A M Parfitt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3063498     DOI： 10.2165/00003495-198836050-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  50 in total

Review 1.  Consensus development conference: prophylaxis and treatment of osteoporosis.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-10

2.  Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.

Authors:  G F Jensen; B Meinecke; J Boesen; I Transbøl
Journal:  Clin Orthop Relat Res       Date:  1985 Jan-Feb       Impact factor: 4.176

3.  Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.

Authors:  G F Jensen; C Christiansen; I Transbøl
Journal:  Clin Endocrinol (Oxf)       Date:  1982-05       Impact factor: 3.478

4.  Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation.

Authors:  R M Francis; M Peacock; J E Aaron; P L Selby; G A Taylor; J Thompson; D H Marshall; A Horsman
Journal:  Bone       Date:  1986       Impact factor: 4.398

5.  Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females.

Authors:  C Christiansen; M S Christensen; P McNair; C Hagen; K E Stocklund; I Transbøl
Journal:  Eur J Clin Invest       Date:  1980-08       Impact factor: 4.686

Review 6.  Osteoporosis, calcium and physical activity.

Authors:  A D Martin; C S Houston
Journal:  CMAJ       Date:  1987-03-15       Impact factor: 8.262

7.  Vitamin D toxicity complicating the treatment of senile, postmenopausal, and glucocorticoid-induced osteoporosis. Four case reports and a critical commentary on the use of vitamin D in these disorders.

Authors:  M S Schwartzman; W A Franck
Journal:  Am J Med       Date:  1987-02       Impact factor: 4.965

8.  Calcium malabsorption in elderly women with vertebral fractures: evidence for resistance to the action of vitamin D metabolites on the bowel.

Authors:  R M Francis; M Peacock; G A Taylor; J H Storer; B E Nordin
Journal:  Clin Sci (Lond)       Date:  1984-01       Impact factor: 6.124

9.  1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women.

Authors:  R J Duda; R Kumar; K I Nelson; A R Zinsmeister; K G Mann; B L Riggs
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

10.  Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase.

Authors:  A M Parfitt; L S Simon; A R Villanueva; S M Krane
Journal:  J Bone Miner Res       Date:  1987-10       Impact factor: 6.741
View more
  2 in total

1.  Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women.

Authors:  K T Khaw; M J Sneyd; J Compston
Journal:  BMJ       Date:  1992-08-01

2.  Short-term course of 1,25(OH)2D3 stimulates osteoblasts but not osteoclasts in osteoporosis and osteoarthritis.

Authors:  P Geusens; D Vanderschueren; A Verstraeten; J Dequeker; P Devos; R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.